Lantheus holdings address
Webb14 apr. 2024 · Oregon Public Employees Retirement Fund trimmed its position in Lantheus Holdings, Inc. (NASDAQ:LNTH - Get Rating) by 10.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC).The institutional investor owned 20,237 shares of the … Webb9 apr. 2024 · NASDAQ LNTH opened at $83.10 on Friday. Lantheus Holdings, Inc. has a 1-year low of $47.46 and a 1-year high of $87.47. The company has a current ratio of 2.74, a quick ratio of 2.59 and a debt-to ...
Lantheus holdings address
Did you know?
Webb6 feb. 2024 · 99.1 Press Release of Lantheus Holdings, Inc. dated February 6, 2024, entitled "Lantheus Announces Acquisition of Cerveau Technologies, Inc., Expanding … Webb13 juni 2024 · Study Results Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in Vancouver. NORTH BILLERICA, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH) is committed to improving patient outcomes through diagnostics, …
WebbLantheus Holdings, Inc. LNTH: Raising target price to $87.00 LANTHEUS HOLDINGS INC has an Investment Rating of HOLD; a target price of $87.000000; an Industry … Webb29 mars 2024 · Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and …
Webb17 mars 2024 · Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com. Contacts: Mark Kinarney Vice President, Investor Relations 978-671-8842 [email protected] Melissa Downs Senior Director, Corporate Communications 646-975-2533 … Webb800-299-3431 Fax 978-671-8860 Fax Orders/POs 978-436-7501 Email [email protected] Hours 7:30 a.m. to 6:00 p.m. Eastern Time Zone, Monday to …
Webb11 maj 2024 · North Billerica, MA: Progenics Pharmaceuticals, Inc., a Lantheus company. Contacts: Mark Kinarney Senior Director, Investor Relations 978-671-8842 [email protected]. Melissa Downs Senior Director, Corporate Communications 646-975-2533 [email protected]. Source: Lantheus Holdings, Inc.
Webb24 feb. 2024 · North Billerica, MA: Progenics Pharmaceuticals, Inc., a Lantheus company Media Contact: Erich Sandoval Lazar-FINN Partners [email protected] (917) 497-2867 Source: Palette Life Sciences 2024 GlobeNewswire, Inc., source Press Releases Financials (USD) Technical analysis trends LANTHEUS HOLDINGS, INC. … healthy cookie recipes tana amenWebb6 apr. 2024 · Lantheus Holdings, Inc. (NasdaqGM:LNTH) acquired Cerveau Technologies, Inc. on February 6, 2024. Under the terms of the agreement, Lantheus will pay an upfront payment and potential additional development and commercial milestone payments. Additionally, Lantheus will pay double-digit royalty payments for research … healthy cookies peanut butterWebb9 apr. 2024 · Trellus Management Company LLC bought a new position in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH - Get Rating) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 5,743 shares of the medical equipment provider's sto motor speed controller induction runWebbLantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine ... motor speed curveWebb14 apr. 2024 · Lantheus had a net margin of 3.00% and a return on equity of 51.60%. Sell-side analysts anticipate that Lantheus Holdings, Inc. will post 4.46 earnings per share … healthy cookies recipeWebb10 apr. 2024 · Xponance Inc. raised its holdings in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH – Get Rating) by 172.5% in the 4th quarter, according to its most … motor speed control dcWebb29 mars 2024 · Lantheus Holdings, Inc. announced a strategic collaboration with Novartis to include PYLARIFY® (piflufolastat F18) in prostate cancer clinical trials with Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan). PYLARIFY, approved by the FDA in May 2024, ... motor speed control arduino